€1,665.00–€2,669.00Price range: €1,665.00 through €2,669.00
Select options
This product has multiple variants. The options may be chosen on the product page
Kadcyla (trastuzumab emtansine) is a cancer medicine used to treat advanced or metastatic HER2-positive breast cancer (cancer that has spread to other parts of the body) in adults who have previously received trastuzumab and a taxane.